Grants

Extramural Grants

Title:           “How nicotine sensitivity in adulthood is altered by adolescent antipsychotic treatment: A preclinical investigation.”

Role:           Principal Investigator

Agency:       Nebraska Health and Human Services

Type:          Research grant

Period:        07/01/2015-06/30/2016

Total cost:  $50,000



Title:           “Adolescence neurogenesis mechanisms of antipsychotic sensitization and tolerance”

Role:           Principal Investigator

Agency:       DHHS-Nat Inst Child Health Human Dev

Type:          1R03HD079870-01A1

Period:        02/20/2015-01/31/2017

Total cost:  $104,736



Title:           “Serotonin, Maternal Behavior and Postpartum Depression”

Role:           Principal Investigator

Agency:       DHHS-Nat Inst Mental Health

Type:          R01MH097718

Period:        06/01/2013-03/31/2018

Total cost:  $1,497,476

 

Title:           “Behavioral mechanisms of antipsychotic action”

Role:           Principal Investigator

Agency:       DHHS-Nat Inst Mental Health

Type:          R01MH085635

Period:        03/22/2010-01/31/2015

Total cost:  $1,447,532

 

Title:           “Mechanisms of Synaptic Alterations in a Neuroinflammation Model of Autism”

Role:           Co-Investigator

Agency:       Department of Defense (DoD) FY12 Autism Research Program

Type:          AR120096

Period:        09/01/2013-08/31/2015

Total cost:  $xxx,xxx

 

Title:           “Iptakalim for nicotine use in schizophrenia: A preclinical test”

Role:           Principal Investigator

Agency:       Nebraska Health and Human Services

Type:          Research grant

Period:        07/01/2010-06/30/2011

Total cost:  $40,000

 

Title:           “Anxiolytic Property of Atypical Antipsychotics”

Role:           Principal Investigator

Agency:       DHHS-Nat Inst Mental Health

Type:          R21 MH079894

Period:        01/01/2008-12/31/2010

Total cost:  $362,145

 

Title:           “Antipsychotic Drugs and Maternal Behavior: A Preclinical Investigation”

Role:           Principal Investigator

Agency:       DHHS-Nat Inst Mental Health

Type:          R03 MH080822

Period:        09/15/2007-07/31/2010

Total cost:  $132,750

 

Title:           “Iptakalim: A Potential Antipsychotic Drug with Novel Mechanisms”

Role:           Principal Investigator

Agency:       Stanley Medical Research Institute

Type:          Research grant

Period:        08/2007-07/2010

Total cost:  $150,000



Title:           “Behavioral Mechanisms of Action of Atypical Antipsychotics: A Preclinical Investigation”

Role:           Principal Investigator

Agency:       National Alliance for Research on Schizophrenia and Depression (NARSAD)

Type:          Young Investigator Award

Period:        07/2007-06/2010

Total cost:  $60,000



Title:           “Nicotine Effects in Adolescent and Adult Rats”

Role:           Principal Investigator

Agency:       Nebraska Health and Human Services

Type:          Research grant (2008-03B)

Period:        07/01/2008-06/30/2009

Total cost:  $40,000

 

Intramural Grants 

UNL Layman New Direction award (role: PI, June 2012-May 2013): Central Receptor Mechanisms of Antipsychotic Drugs: A Central Infusion Study, $16,108

NU Nebraska Research Initiative Grant (role: co-I, PI: Anna Dunaevsky, 7/1/12- 6/30/13): Nanotherapeutics in Neuroinflammation Model of Autism, $100,000

UNL Life Sciences Competitive Grants (Role: co-I: 07/2011-06/2013): Gene Therapy Against Neurodegenerative Disorders Associated with Pesticide Exposure, $72,000

Faculty seed grant (role: PI, 2008-2009): Characterizing Reconsolidation of Persistent Avoidance Responding, $9,943

Faculty seed grant (role: PI, 2006-2007): How Antipsychotic Drugs Work Psychologically?---An Animal Behavioral Investigation, $9,980

UNL Layman award (role: PI, co-I: Dr. Bevins, June 2006-May 2007): Persistent Avoidance Responding as an Animal Model of Schizophrenia, $9,995

 

Sponsored NIH Fellowships

Natashia Swalve: “Novel hypothesis for the comorbidity of schizophrenia and nicotine abuse in rats”; NIH 1 F31 DA034407-01; Dates: 09/01/2012 - 08/13/2014

Sergios Charntikov: “Role of dmCPu in acquisition and expression of nicotine CS evoked CR”; NIH 1F31DA034449-01A1; Dates: 04/01/2013-03/31/2015